Updated on 13 February 2014
Mr Alex Hungate, president and CEO, SATS said, "As a leader in gateway services, we are constantly driving innovation and service improvements. The development of SATS Coolport as the first Center of Excellence in Pharmaceutical Handling will give our airline customers and global shippers further assurance that their pharmaceutical shipments are handled to the most exacting standards."
He added, "With this milestone and the growing demand for end-to-end, assured handling of high value pharmaceutical products, SATS will look at extending our state-of-the-art cold chain capabilities to our other operations across Asia."
"As we celebrate 100 years of commercial aviation, we are reminded of the value that our industry brings. Aviation is a global partner of the pharmaceutical industry in ensuring critical medicines reach patients in a timely manner at a constant temperature, preserving their integrity. The shipping of pharmaceutical products is the fastest growing market segment in the air freight industry. I congratulate SATS Coolport in their successful completion of the assessment as a Centre of Excellence in Pharmaceutical Handling," said Mr Tony Tyler, director general and CEO, IATA.
Mr Yap Ong Heng, director general, Civil Aviation Authority of Singapore (CAAS), said that, "SATS Coolport's certification as the world's first Center of Excellence in Pharmaceutical Handling reinforces a niche of excellence that will strengthen the Singapore aviation hub and the air cargo and logistics sector here. This achievement will certainly enhance Changi Airport and Singapore's position as a choice location for pharmaceutical air freight. CAAS is pleased to support the SATS collaboration with IATA in building this novel, distinctive capability through our Aviation Innovation Programme."